WTO notification · TBT
JapanUpdated: check whether it is now adopted or in force
Official title
Establishment of the Japanese Pharmacopoeia Nineteenth Edition
Japan issued an addendum on 10 April 2026 to the earlier TBT notification G/TBT/N/JPN/882. Addenda often report that a measure was adopted, changed, postponed or withdrawn. The measure was first notified on 17 October 2025. The comment period closed on 16 December 2025.
Expodite puts notifications like this one in your Updates centre, matched to the HS codes of your products and the markets you export to. Opens the requirements check for Japan in your Expodite account.
Source: WTO ePing (opens in a new tab). Summaries by Expodite, which is independent of the WTO.
Published here:
Updated here:
Pharmaceutical Products (HS:30)
The comment period closed on 16 December 2025. You can still raise concerns about the measure with your country's WTO TBT enquiry point, quoting the document symbol G/TBT/N/JPN/882/Add.1; it can take them up with Japan.
Find your country's enquiry point on WTO ePing (opens in a new tab)Latest notice (G/TBT/N/JPN/882/Add.1, 10 April 2026)
Establishment of the Japanese Pharmacopoeia Nineteenth Edition（JP19）
The draft revision to establish Japanese Pharmacopoeia Nineteenth Edition notified in G/TBT/N/JPN/882 will be published and enter into force on 10 April 2026. The Japanese Pharmacopoeia Nineteenth Edition in English is planned to be published in due course.
Ministry of Health, Labour and Welfare will abolish the Japanese Pharmacopoeia Eighteenth Edition and establish Nineteenth Edition based on Paragraph 1 of Article 41 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices.
Every notice about this measure published here, newest first. Each one is the notifying member's own text.
AddendumG/TBT/N/JPN/882/Add.1
Establishment of the Japanese Pharmacopoeia Nineteenth Edition（JP19）
The draft revision to establish Japanese Pharmacopoeia Nineteenth Edition notified in G/TBT/N/JPN/882 will be published and enter into force on 10 April 2026. The Japanese Pharmacopoeia Nineteenth Edition in English is planned to be published in due course.
Regular notificationG/TBT/N/JPN/882
Comment deadline: Closed on 16 December 2025
Establishment of the Japanese Pharmacopoeia Nineteenth Edition
Ministry of Health, Labour and Welfare will abolish the Japanese Pharmacopoeia Eighteenth Edition and establish Nineteenth Edition based on Paragraph 1 of Article 41 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices.
Expodite writes its summary from the official record. The notification and the documents it notifies are on the WTO's own websites.
WTO notificationSPSProposed measure, not in force yetNew
Specifies Potassium Acetate as those unlikely to harm human health and Establishment to the standards for Potassium Acetate.
Symbol: G/SPS/N/JPN/1437
WTO notificationSPSProposed measure, not in force yetNew
Proposal of maximum residue limits (MRLs) for the following agricultural chemical Pesticide: 1,3-Dichloropropene
Symbol: G/SPS/N/JPN/1436
WTO notificationSPSProposed measure, open for commentsNew
Proposal of maximum residue limits (MRLs) for the following agricultural chemical Pesticide: Fenazaquin
Symbol: G/SPS/N/JPN/1435Comments until 29 December 2026
WTO notificationSPSProposed measure, not in force yetNew
Proposal of maximum residue limits (MRLs) for the following agricultural chemical Pesticide: Tiadinil
Symbol: G/SPS/N/JPN/1434
Expodite matches each notification to the markets you export to and the HS codes of your products, and puts the ones that concern you in your Updates centre, with the date comments close.